Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fibroblast Growth Factor 23 Associates with Death in Critically Ill Patients.
Leaf DE, Siew ED, Eisenga MF, Singh K, Mc Causland FR, Srivastava A, Alp Ikizler T, Ware LB, Ginde AA, Kellum JA, Palevsky PM, Wolf M, Waikar SS. Leaf DE, et al. Among authors: eisenga mf. Clin J Am Soc Nephrol. 2018 Apr 6;13(4):531-541. doi: 10.2215/CJN.10810917. Epub 2018 Mar 8. Clin J Am Soc Nephrol. 2018. PMID: 29519954 Free PMC article.
Iron, Hepcidin, and Death in Human AKI.
Leaf DE, Rajapurkar M, Lele SS, Mukhopadhyay B, Boerger EAS, Mc Causland FR, Eisenga MF, Singh K, Babitt JL, Kellum JA, Palevsky PM, Christov M, Waikar SS. Leaf DE, et al. Among authors: eisenga mf. J Am Soc Nephrol. 2019 Mar;30(3):493-504. doi: 10.1681/ASN.2018100979. Epub 2019 Feb 8. J Am Soc Nephrol. 2019. PMID: 30737269 Free PMC article.
Effects of erythropoietin on fibroblast growth factor 23 in mice and humans.
Hanudel MR, Eisenga MF, Rappaport M, Chua K, Qiao B, Jung G, Gabayan V, Gales B, Ramos G, de Jong MA, van Zanden JJ, de Borst MH, Bakker SJL, Nemeth E, Salusky IB, Gaillard CAJM, Ganz T. Hanudel MR, et al. Among authors: eisenga mf. Nephrol Dial Transplant. 2019 Dec 1;34(12):2057-2065. doi: 10.1093/ndt/gfy189. Nephrol Dial Transplant. 2019. PMID: 30007314 Free PMC article.
Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.
De Jong MA, Eisenga MF, van Ballegooijen AJ, Beulens JWJ, Vervloet MG, Navis G, Gansevoort RT, Bakker SJL, De Borst MH. De Jong MA, et al. Among authors: eisenga mf. Nephrol Dial Transplant. 2021 Jan 1;36(1):121-128. doi: 10.1093/ndt/gfz266. Nephrol Dial Transplant. 2021. PMID: 32124925 Free PMC article.
Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference.
Babitt JL, Eisenga MF, Haase VH, Kshirsagar AV, Levin A, Locatelli F, Małyszko J, Swinkels DW, Tarng DC, Cheung M, Jadoul M, Winkelmayer WC, Drüeke TB; Conference Participants. Babitt JL, et al. Among authors: eisenga mf. Kidney Int. 2021 Jun;99(6):1280-1295. doi: 10.1016/j.kint.2021.03.020. Epub 2021 Apr 8. Kidney Int. 2021. PMID: 33839163 Free article.
Epoetin Beta and C-Terminal Fibroblast Growth Factor 23 in Patients With Chronic Heart Failure and Chronic Kidney Disease.
Eisenga MF, Emans ME, van der Putten K, Cramer MJ, Diepenbroek A, Velthuis BK, Doevendans PA, Verhaar MC, Joles JA, Bakker SJL, Nolte IM, Braam B, Gaillard CAJM. Eisenga MF, et al. J Am Heart Assoc. 2019 Aug 20;8(16):e011130. doi: 10.1161/JAHA.118.011130. Epub 2019 Aug 17. J Am Heart Assoc. 2019. PMID: 31423921 Free PMC article. Clinical Trial.
106 results